No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Cytarabine / administration & dosage
-
Dexamethasone / administration & dosage
-
Female
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / genetics
-
Male
-
Middle Aged
-
Rituximab
-
Tumor Suppressor Protein p53 / physiology
-
Vidarabine / analogs & derivatives*
-
Vidarabine / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Tumor Suppressor Protein p53
-
Cytarabine
-
Rituximab
-
Dexamethasone
-
Vidarabine
-
fludarabine
-
Cisplatin